This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "GenomicVariantObservation FHIR Profile Proposal"

From HL7Wiki
Jump to navigation Jump to search
Line 121: Line 121:
 
Choose one:
 
Choose one:
 
*Ballot with next FHIR DSTU or Normative Edition
 
*Ballot with next FHIR DSTU or Normative Edition
*or Ballot independently as DSTU
+
 
*or Realm specific ballot
 
*or No Ballot
 
  
 
<!-- Indicate the desired ballot date.-->
 
<!-- Indicate the desired ballot date.-->
 
Desired Ballot Date
 
Desired Ballot Date
 
*PutDesiredBallotDateHere
 
*PutDesiredBallotDateHere

Revision as of 02:40, 20 May 2014



GeneticVariantObservation

Resource Details

Parent Resource

Constraints to be Applied

  • Constraints to integrate clinical genomic standards into FHIR, as outlined in

HL7 Version 2 Implementation Guide: Clinical Genomics; Fully LOINC-Qualified Genetic Variation Model, Release 2

Version 2 Implementation Guide: Clinical Genomics; Fully LOINC-Qualified Genetic Variation Model, Release 1 (US Realm)
  • Extensions to support genomic coordinates will be coded in LOINC and added to these terms
  • Additional extensions maybe added as necessary.
    • Note the use of LOINC codes to qualify genetic/genomic results will be strongly recommended but not required.
    • Additionally, using LOINC to qualify genetic/genomic data has also been demonstrated in the following:

HL7 IG for CDA R2: Genetic Testing Reports, Release 1 - GTR

Implementation Guide for CDA® Release 2: Genetic Testing Reports, Release 1
  • Finally, the genetic/genomic information will be aligned with the Clinical Genomic DAM and DIM currently underdevelopment
    • The DAM & DIM will also be backwards compatible to the v.2.5.1 and CDA Genetic Test Report (mentioned above)

Extensions to be Applied

  • See above

Example Scenarios

  • Full scenarios are outlined within the v 2.5.1 IG for genetic test reporting and the DAM. These include:
    • Genetic test reporting of gene variants found without interpretation, with interpretation associated with drug efficacy and/or resistance, drug metabolism, disease diagnosis, and disease risk
    • Transmission of a genetic/genomic data file containing 'raw' data from the test

Scope of coverage

  • Human
  • Clinical testing scenarios, clinical trails, and translational medicine
  • Universal with match to guidance to US Realm


Ownership

Owning committee name

Clinical Genomics Workgroup

Contributing or Reviewing Work Groups

  • Anatomic Pathology
  • Orders and Observations
  • Image Integration

Expected implementations

  • Harvard - Partners
  • Haifa University
  • Intermountain Healthcare

gForge Users

FHIR Profile Development Project Insight ID

Plans

Timelines

  • TargetDateForInternalReview

Balloting Requirements

Choose one:

  • Ballot with next FHIR DSTU or Normative Edition


Desired Ballot Date

  • PutDesiredBallotDateHere